Comparative evaluation of safety parameters at the preclinical and clinical stages of the study of the Reamberin® (LLC "POLYSAN")
V. B. Vasilyuk, M. V. Faraponova, G. I. Syraeva, A. B. Verveda, A. V. Belskaya, A. V. Shults, L. G. Kubarskaya, E. A. Zolotoverkhaya
Published in Фармакокинетика и Фармакодинамика (21.12.2022)
Published in Фармакокинетика и Фармакодинамика (21.12.2022)
Get full text
Journal Article